Yunkang Group (HKG:2325) expects a net loss between 663 million yuan and 856 million yuan in 2024, wider than 101.9 million yuan in 2023, a Tuesday Hong Kong bourse filing said.
The medical operation service provider attributed the expected wider loss to lower revenue from diagnostic testing services due to market conditions and higher provision for credit impairment losses, optimization expenses, and research and development expenses.
Price (HKD): $4.87, Change: $-0.0100, Percent Change: -0.20%